ARTICLE | Clinical News
NovoMix 30: Post-marketing study data
November 9, 2009 8:00 AM UTC
Data from an open-label, post-marketing study in 708 patients with suboptimal glycated HbA1c levels while on metformin and sulfonylurea showed that there was no significant difference in median glycat...